Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Cited by (1,000)

Items 201–300 of 1,000

1. Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
   Sriram Venneti, Clayton A. Wiley, Julia Kofler · 2008 · Journal of Neuroimmune Pharmacology
2. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology
   Jeroen J.M. Hoozemans, Robert Veerhuis, Annemieke J.M. Rozemüller, Piet Eikelenboom · 2005 · International Journal of Developmental Neuroscience
3. Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
   Martin C. Herzig, William E. Van Nostrand, Mathias Jucker · 2006 · Brain Pathology
4. Failure of Perivascular Drainage of β‐amyloid in Cerebral Amyloid Angiopathy
   Cheryl A. Hawkes, Nimeshi Jayakody, David Annandale Johnston, Ingo Bechmann, Roxana Octavia Carare · 2014 · Brain Pathology
5. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
   John Tiernan O'Brien, Alistair S. Burns · 2010 · Journal of Psychopharmacology
6. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice
   Ribé, Elena M., Pérez, Mar, Puig, Berta, Gich, Ignasi, Lim, Filip, Cuadrado, Mar, Sesma, Teresa, Catena, Silvia, Sánchez, Belén, Nieto, María et al. · 2005 · Neurobiology of Disease
7. Disrupting β-Amyloid Aggregation for Alzheimer Disease Treatment
   Lisbell D. Estrada, Claudio A. Soto · 2006 · Current Topics in Medicinal Chemistry
8. Disease‐modifying therapies in Alzheimer's disease
   Stephen Salloway, Jacobo E Mintzer, Myron Weiner, Jeffrey L. Cummings · 2008 · Alzheimer s & Dementia
9. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy
   A. Vendrely, Boris Bienvenu, Jacques Gasnault, Jean Baptiste Thiebault, Dominique Salmon, Françoise Gray · 2005 · Acta Neuropathologica
10. Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease
    Clayton A. Wiley, Brian J. Lopresti, Sriram Venneti, Julie C. Price, William Edward Klunk, Steven Trent DeKosky, Chester A. Mathis · 2009 · Archives of Neurology
11. Perivascular spaces and brain waste clearance systems: relevance for neurodegenerative and cerebrovascular pathology
    Kaylene Gouveia-Freitas, António José de Bastos-Leite · 2021 · Neuroradiology
12. Beneficial effect of human anti-amyloid-β active immunization on neurite morphology and tau pathology
    Serrano-Pozo, Alberto, William, Christopher M., Ferrer, Isidro, Uro-Coste, Emmanuelle, Delisle, Marie-Bernadette, Maurage, Claude-Alain, Hock, Christoph, Nitsch, Roger M., Masliah, Eliezer, Growdon, John H. et al. · 2010 · Brain
13. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer?s disease*1Pro-CAA position statement
    James A. R. Nicoll, Masahito Yamada, Janusz Frackowiak, Bozena Mazur‐Kolecka, Roy O. Weller · 2004 · Neurobiology of Aging
14. Aβ-induced meningoencephalitis is IFN-γ-dependent and is associated with T cell-dependent clearance of Aβ in a mouse model of Alzheimer's disease
    Alon Monsonego, Jaime Imitola, Sanja Petrovic, Victor E. Zota, Anna Nemirovsky, Rona Baron, Yair Fisher, Trevor Owens, Howard L. Weiner · 2006 · Proceedings of the National Academy of Sciences
15. Amyloid‐ß‐directed immunotherapy for Alzheimer's disease
    Lars Lannfelt, Norman R. Relkin, Eric Siemers · 2014 · Journal of Internal Medicine
16. Fatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer’s disease
    Elena Solopova, Wilber Romero‐Fernandez, Hannah J. Harmsen, Lissa Ventura‐Antunes, Emmeline Wang, Alena Shostak, Jose Maldonado, Manus Joseph Donahue, Daniel Schultz, Thomas M. Coyne et al. · 2023 · Nature Communications
17. Immunotherapy for Alzheimer's disease
    David S. Gélinas, Kevin Da Silva, Daniela Fenili, Peter St George‐Hyslop, JoAnne McLaurin · 2004 · Proceedings of the National Academy of Sciences
18. Amyloid-β immunisation for Alzheimer's disease
    Wisniewski, Thomas, Konietzko, Uwe · 2008 · The Lancet Neurology
19. Deglycosylated Anti-Amyloid-β Antibodies Eliminate Cognitive Deficits and Reduce Parenchymal Amyloid with Minimal Vascular Consequences in Aged Amyloid Precursor Protein Transgenic Mice
    Donna M. Wilcock, Jennifer Alamed, Paul E. Gottschall, Jan Grimm, Arnon Rosenthal, Jaume Pons, Victoria Ronan, Keisha Symmonds, Marcia N. Gordon, David Morgan · 2006 · Journal of Neuroscience
20. Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
    Honjo, Kie, Black, Sandra E., Verhoeff, Nicolaas P. L. G. · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
21. Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
    Lars Lannfelt, Christer Möller, Hans Basun, Gunilla Osswald, Dag Sehlin, Andrew Satlin, Veronika Logovinsky, Pär Gellerfors · 2014 · Alzheimer s Research & Therapy
22. Biological Marker Candidates of Alzheimer's Disease in Blood, Plasma, and Serum
    Philine Schneider, Harald Juergen Hampel, Katharina Büerger · 2009 · CNS Neuroscience & Therapeutics
23. APOE-ε2 and APOE-ε4 Correlate With Increased Amyloid Accumulation in Cerebral Vasculature
    Nelson, Peter T., Pious, Nina M., Jicha, Gregory A., Wilcock, Donna M., Fardo, David W., Estus, Steven, Rebeck, G. William · 2013 · Journal of Neuropathology & Experimental Neurology
24. Amyloid-β Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations
    Lombardo, Julianne A., Stern, Edward A., McLellan, Megan E., Kajdasz, Stephen T., Hickey, Gregory A., Bacskai, Brian J., Hyman, Bradley T. · 2003 · The Journal of Neuroscience
25. Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease
    Gomez-Nicola, Diego, Boche, Delphine · 2015 · Alzheimer's Research & Therapy
26. CD4+ effector T cells accelerate Alzheimer’s disease in mice
    Jatin Machhi, Pravin Yeapuri, Yaman Lu, Emma G. Foster, Rupesh V. Chikhale, Jonathan Herskovitz, Krista L. Namminga, Katherine E. Olson, Mai Mohamed Abdelmoaty, Ju Gao et al. · 2021 · Journal of Neuroinflammation
27. Transgenic mouse models of Alzheimer's disease: phenotype and application.
    2003 · PubMed
28. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models
    Sebastian Monasor, Laura, Müller, Stephan A, Colombo, Alessio Vittorio, Tanrioever, Gaye, König, Jasmin, Roth, Stefan, Liesz, Arthur, Berghofer, Anna, Piechotta, Anke, Prestel, Matthias et al. · 2020 · eLife
29. Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease
    Lynn van Olst, Brooke Simonton, Alex J. Edwards, Anne V. Forsyth, Jake Sondag Boles, Pouya Jamshidi, Thomas H. Watson, Nate Shepard, Talia Krainc, Benney MR Argue et al. · 2025 · Nature Medicine
30. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
    Roy O. Weller, Stephen Preston, Malavika Subash, Roxana Octavia Carare · 2009 · Alzheimer s Research & Therapy
31. Oral vaccination with a viral vector containing Aβ cDNA attenuates age‐related Aβ accumulation and memory deficits without causing inflammation in a mouse Alzheimer model
    Akihiro Mouri, Yukihiro Noda, Hideo Hara, Hiroyuki Mizoguchi, Takeshi Tabira, Toshitaka Nabeshima · 2007 · The FASEB Journal
32. IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
    Shimizu, Eisuke, Kawahara, Kohichi, Kajizono, Makoto, Sawada, Makoto, Nakayama, Hitoshi · 2008 · The Journal of Immunology
33. Neuroinflammatory responses in Alzheimer’s disease
    Cira Dansokho, Michael Thomas Heneka · 2017 · Journal of Neural Transmission
34. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
    K. A. Jellinger, Johannes Attems · 2004 · Journal of the Neurological Sciences
35. Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1
    Iijima-Ando, Kanae, Sekiya, Michiko, Maruko-Otake, Akiko, Ohtake, Yosuke, Suzuki, Emiko, Lu, Bingwei, Iijima, Koichi M. · 2012 · PLoS Genetics
36. From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation
    Romain Goulay, Luis Mena Romo, Elly M. Hol, Rick M. Dijkhuizen · 2019 · Translational Stroke Research
37. Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches
    Julien Delrieu, Pierre‐Jean Ousset, Céline Caillaud, Bruno J. Vellas · 2011 · Journal of Neurochemistry · Retracted
38. PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
    Venneti, Sriram, Lopresti, Brian J., Wang, Guoji, Hamilton, Ronald L., Mathis, Chester A., Klunk, William E., Apte, Udayan M., Wiley, Clayton A. · 2009 · Neurobiology of Aging
39. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances
    Thal, Dietmar Rudolf, Capetillo-Zarate, Estibaliz, Larionov, Sergey, Staufenbiel, Matthias, Zurbruegg, Stefan, Beckmann, Nicolau · 2009 · Neurobiology of Aging
40. The amyloid cascade hypothesis
    Amos D. Korczyn · 2008 · Alzheimer s & Dementia
41. Targeting the JAK2/STAT3 axis in Alzheimer's disease
    Tomohiro Chiba, Marina Yamada, Sadakazu Aiso · 2009 · Expert Opinion on Therapeutic Targets
42. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
    Jatin Machhi, Bhavesh D. Kevadiya, Ijaz Khan Muhammad, Jonathan Herskovitz, Katherine E. Olson, Rodney Lee Mosley, Howard Eliot Gendelman · 2020 · Molecular Neurodegeneration
43. Human anti- -amyloid antibodies block -amyloid fibril formation and prevent -amyloid-induced neurotoxicity
    Yansheng Du · 2003 · Brain
44. Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
    Boche, Delphine, Denham, Nathan, Holmes, Clive, Nicoll, James A. R. · 2010 · Acta Neuropathologica
45. Alzheimer's-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal
    Pitt, Jason, Roth, William, Lacor, Pascale, Smith, Amos B., Blankenship, Matthew, Velasco, Pauline, De Felice, Fernanda, Breslin, Paul, Klein, William L. · 2009 · Toxicology and Applied Pharmacology
46. Parenchymal and vascular Aβ‐deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease
    Thal, Dietmar Rudolf, Griffin, W. Sue T., Braak, Heiko · 2008 · Journal of Cellular and Molecular Medicine
47. Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune Response
    Marcel Maier, Timothy J. Seabrook, Noel D. Lazo, Liying Jiang, Pritam Das, Christopher Janus, Cynthia Ann Lemere · 2006 · Journal of Neuroscience
48. The Experimental Alzheimer’s Disease Drug Posiphen [(+)-Phenserine] Lowers Amyloid-β Peptide Levels in Cell Culture and Mice
    Debomoy K. Lahiri, De‐Mao Chen, Bryan Maloney, Harold W. Holloway, Qian-sheng Yu, Tada Utsuki, Tony Giordano, Kumar Sambamurti, Nigel H. Greig · 2006 · Journal of Pharmacology and Experimental Therapeutics
49. Current progress in beta-amyloid immunotherapy
    Dale Schenk, Michael Hagen, Peter A. Seubert · 2004 · Current Opinion in Immunology
50. The endocytic pathway in microglia during health, aging and Alzheimer’s disease
    Solé-Domènech, Santiago, Cruz, Dana L., Capetillo-Zarate, Estibaliz, Maxfield, Frederick R. · 2016 · Ageing Research Reviews
51. Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
    Schroeter, S., Khan, K., Barbour, R., Doan, M., Chen, M., Guido, T., Gill, D., Basi, G., Schenk, D., Seubert, P. et al. · 2008 · Journal of Neuroscience
52. The role of amyloid-beta in the regulation of memory
    John Edward Morley, Susan A. Farr · 2014 · Biochemical Pharmacology
53. Genetics of Alzheimer's disease: new evidences for an old hypothesis?
    Jean‐Charles Lambert, Philippe Amouyel · 2011 · Current Opinion in Genetics & Development
54. The systemic amyloidoses
    Joel N. Buxbaum · 2003 · Current Opinion in Rheumatology
55. Development of AFFITOPE vaccines for Alzheimer's disease (AD) — From concept to clinical testing
    Achim Schneeberger, Markus Mandler, O. Otava, Wolfgang Zauner, Frank Mattner, Wolfgang Schmidt · 2009 · The journal of nutrition health & aging
56. Proteolytic mechanisms in amyloid-β metabolism: therapeutic implications for Alzheimer's disease
    Emma R. L. C. Vardy, Andrew J. Catto, Nigel M. Hooper · 2005 · Trends in Molecular Medicine
57. Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions
    Elmaleh, David R., Farlow, Martin R., Conti, Peter S., Tompkins, Ronald G., Kundakovic, Ljiljana, Tanzi, Rudolph E. · 2019 · Journal of Alzheimer’s Disease
58. Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease
    Grace Vitek, Boris Decourt, Marwan Noel Sabbagh · 2023 · Expert Opinion on Investigational Drugs
59. Physicochemical characteristics of soluble oligomeric Aβand their pathologic role in Alzheimer's disease
    Desiree Watson, Eduardo Castaño, Tyler A. Kokjohn, Yu‐Min Kuo, Yuri L. Lyubchenko, David J. Pinsky, Edward Sander Connolly, Chera L. Esh, Dean C. Luehrs, W. Blaine Stine et al. · 2005 · Neurological Research
60. Aβ42 immunization in Alzheimer's disease generates Aβ N-terminal antibodies
    Michael Lee, Frédérique Bard, Kelly Johnson‐Wood, Celeste Lee, Kang Hu, Sue G. Griffith, Ronald S. Black, Dale Schenk, Peter A. Seubert · 2005 · Annals of Neurology
61. Treatment Strategies Targeting Amyloid -Protein
    Dale Schenk, G.S. Basi, Menelas N. Pangalos · 2012 · Cold Spring Harbor Perspectives in Medicine
62. Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
    Qiang Zhang, Guanhu Yang, Yuan Luo, Lai Jiang, Hao Chi, Gang Tian · 2024 · Immunity & Ageing
63. Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice
    Ewa Hellström‐Lindahl, JENNIFER A. COURT, Jessica Keverne, Marie M. Svedberg, Mandy Lee, Amelia Marutle, Alan J. Thomas, Elaine King Perry, I. Bednar, Agneta K. Nordberg · 2004 · European Journal of Neuroscience
64. Immunotherapy for Alzheimer‘s Disease: From Anti-β-Amyloid to Tau-Based Immunization Strategies
    Francesco Panza, Vincenza Frisardi, Vincenzo Solfrizzi, Bruno Pietro Imbimbo, Giancarlo Logroscino, Andrea Santamato, Antonio Greco, Davide Seripa, Alberto Pilotto · 2012 · Immunotherapy
65. Protein misfolding in neurodegenerative diseases
    Eleftherios I. Agorogiannis, G. I. Agorogiannis, Alexandros Papadimitriou, George M. Hadjigeorgiou · 2004 · Neuropathology and Applied Neurobiology
66. Phagocytosis of Amyloid-β and Inflammation: Two Faces of Innate Immunity in Alzheimer's Disease
    Milan Fiala, David H. Cribbs, Mark J. Rosenthal, George W. Bernard · 2007 · Journal of Alzheimer s Disease
67. Neuronal death in Alzheimer’s disease and therapeutic opportunities
    Rossen Donev, Martin V. Kolev, Bruno Millet, Johannes Thome · 2009 · Journal of Cellular and Molecular Medicine
68. Alzheimer 100 – highlights in the history of Alzheimer research
    K. A. Jellinger · 2006 · Journal of Neural Transmission
69. Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice
    Thakker, Deepak R., Weatherspoon, Marcy R., Harrison, Jonathan, Keene, Thomas E., Lane, Deanna S., Kaemmerer, William F., Stewart, Gregory R., Shafer, Lisa L. · 2009 · Proceedings of the National Academy of Sciences
70. Multiple sclerosis and Alzheimer's disease
    Dal Bianco, Assunta, Bradl, Monika, Frischer, Josa, Kutzelnigg, Alexandra, Jellinger, Kurt, Lassmann, Hans · 2008 · Annals of Neurology
71. Stages of granulovacuolar degeneration: their relation to Alzheimer’s disease and chronic stress response
    Dietmar Rudolf Thal, Kelly Del Tredici, Albert Christian Ludolph, Jeroen J.M. Hoozemans, Annemieke J.M. Rozemüller, Heiko Braak, Uwe Knippschild · 2011 · Acta Neuropathologica
72. Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?
    Daniela Puzzo, Ottavio Arancio · 2012 · Journal of Alzheimer s Disease
73. Pharmacological Treatment of Alzheimer Disease
    Fadi Massoud, Gabriel C. Léger · 2011 · The Canadian Journal of Psychiatry
74. Untitled work
    2012 · 10.1038/nrneurol.2012.118
75. Therapeutic Strategies for Alzheimer’s Disease
    Donna M. Barten, Charles F. Albright · 2008 · Molecular Neurobiology
76. Amyloid precursor protein transgenic mouse models and Alzheimer's disease: Understanding the paradigms, limitations, and contributions
    Tyler A. Kokjohn, Alex E. Roher · 2009 · Alzheimer s & Dementia
77. APP/Aβ structural diversity and Alzheimer's disease pathogenesis
    Alex E. Roher, Tyler A. Kokjohn, Steven Gerard Clarke, Michael R. Sierks, Chera L. Maarouf, Geidy E. Serrano, Marwan Sabbagh, Thomas G. Beach · 2017 · Neurochemistry International
78. Novel targets for Alzheimer's disease treatment
    J. Grill, J. Cummings · 2010 · Expert Review of Neurotherapeutics
79. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium
    Jeanne E. Bell, Irina I. Alafuzoff, Safa Al‐Sarraj, Thomas Arzberger, Nenad Bogdanović, Herbert Budka, David Trevor Dexter, Peter Falkai, Isidró Ferrer, Elena Gelpi et al. · 2008 · Acta Neuropathologica
80. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
    Claudia Schwab, Masato Hosokawa, Patrick L. McGeer · 2004 · Experimental Neurology
81. Circulating Biomarkers of Cognitive Decline and Dementia
    Solfrizzi, Vincenzo, D'Introno, Alessia, Colacicco, Anna Maria, Capurso, Cristiano, Todarello, Orlando, Pellicani, Vincenza, Capurso, Sabrina A, Pietrarossa, Giuseppe, Santamato, Vito, Capurso, Antonio et al. · 2006 · Clinica Chimica Acta
82. The adult human brain in preclinical drug development
    Mike Dragunow · 2008 · Nature Reviews Drug Discovery
83. Brain banking: opportunities, challenges and meaning for the future
    Hans A. Kretzschmar · 2008 · Nature reviews. Neuroscience
84. Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
    Golde, Todd E. · 2022 · Neurotherapeutics
85. Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis’ still alive?
    Tayeb, Haythum O, Murray, Evan D, Price, Bruce H, Tarazi, Frank I · 2013 · Expert Opinion on Biological Therapy
86. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model
    Wang‐Sheng Jin, Lin‐Lin Shen, Xian‐Le Bu, Weiwei Zhang, Sihan Chen, Zhilin Huang, Jiaxiang Xiong, Chang‐Yue Gao, Zhifang Dong, Yani He et al. · 2017 · Acta Neuropathologica
87. Robust amyloid clearance in a mouse model of Alzheimer’s disease provides novel insights into the mechanism of amyloid-β immunotherapy
    Wang, Allan, Das, Pritam, Switzer, Robert C., Golde, Todd E., Jankowsky, Joanna L. · 2011 · The Journal of Neuroscience
88. Recent rodent models for Alzheimer’s disease: clinical implications and basic research
    Nady Braidy, Pablo Muñoz, Adrián G. Palacios, Gloria Castellano‐González, Nibaldo C. Inestrosa, Roger S. Chung, Perminder Singh Sachdev, Gilles J. Guillemin · 2011 · Journal of Neural Transmission
89. Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
    Marcos Vasconcelos Pais, Luana Dongue Martinez, Octávio Gonçalves Ribeiro, Júlia Cunha Loureiro, Romel Fernandez, Leandro Da Costa Lane Valiengo, Paulo Renato Canineu, Florindo Stella, Leda Leme Talib, Márcia Radanovic et al. · 2020 · Brazilian Journal of Psychiatry
90. Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis
    Michael W. Pride, Peter A. Seubert, Michael Grundman, Michael Hagen, John H. Eldridge, Ronald S. Black · 2008 · Neurodegenerative Diseases
91. Impact of amyloid imaging on drug development in Alzheimer's disease
    Chester A. Mathis, Brian J. Lopresti, William Edward Klunk · 2007 · Nuclear Medicine and Biology
92. Disease modifying therapy for AD?¹
    Golde, Todd E. · 2006 · Journal of Neurochemistry
93. A practical approach to the management of cerebral amyloid angiopathy
    Mariel G. Kozberg, Valentina Perosa, M. Edip Gurol, Susanne J. van Veluw · 2020 · International Journal of Stroke
94. Immunotherapy Targeting Pathological Tau Protein in Alzheimer's Disease and Related Tauopathies
    Sigurdsson, Einar M. · 2008 · Journal of Alzheimer's Disease
95. Cystatin C Protects Neuronal Cells from Amyloid-β-induced Toxicity
    Belén Tizón, Elena M. Ribé, Weiqian Mi, Carol M. Troy, Efrat Levy · 2010 · Journal of Alzheimer s Disease
96. Therapeutic vaccination for chronic diseases: a new class of drugs in sight
    Martin F. Bachmann, Mark R. Dyer · 2003 · Nature Reviews Drug Discovery
97. Small molecule blockers of the Alzheimer Aβ calcium channel potently protect neurons from Aβ cytotoxicity
    Juan Carlos Díaz, Olga Šimáková, Kenneth A. Jacobson, Nelson J. Arispe, Harvey B. Pollard · 2009 · Proceedings of the National Academy of Sciences
98. Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse models
    Levites, Yona, Smithson, Lisa A., Price, Robert W., Dakin, Rachel S., Yuan, Bin, Sierks, Michael R., Kim, Jungsu, McGowan, Eileen, Kim Reed, Dana, Rosenberry, Terrone L. et al. · 2006 · The FASEB Journal
99. Inflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease
    Helga E. de Vries, Gijs Kooij, Dan Frenkel, Spiros Georgopoulos, Alon Monsonego, Damir Janigro · 2012 · Epilepsia
100. Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer’s Disease in a Rat Animal Model: Involvement of STIM Proteins
     Mehdi Sanati, Fariba Khodagholi, Samaneh Aminyavari, Forough Ghasemi, Mahdi Gholami, Abbas Kebriaeezadeh, Omid Sabzevari, Mohammad Javad Hajipour, Mohammad Imani, Morteza Mahmoudi et al. · 2019 · ACS Chemical Neuroscience